¼¼°èÀÇ °£Áúȯ Ä¡·á ½ÃÀå
Liver Disease Treatments: The Global Market
»óǰÄÚµå : 1716269
¸®¼­Ä¡»ç : BCC Research
¹ßÇàÀÏ : 2025³â 04¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 164 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,650 £Ü 6,464,000
PDF & Excel (Single User License) help
PDF ¹× Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,580 £Ü 7,757,000
PDF & Excel (2-5 Users) help
PDF ¹× Excel º¸°í¼­¸¦ 2-5¸íÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,696 £Ü 9,309,000
PDF & Excel (Site License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,035 £Ü 11,171,000
PDF & Excel (Enterprise License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°è °£Áúȯ Ä¡·á ½ÃÀå ±Ô¸ð´Â 2024³â 460¾ï ´Þ·¯¿¡¼­ ¿¹Ãø ±â°£ µ¿¾È 7.1%ÀÇ CAGR·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 691¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÏ¹Ì ½ÃÀåÀº 2024³â 208¾ï ´Þ·¯¿¡¼­ ¿¹Ãø ±â°£ µ¿¾È 7.3%ÀÇ CAGR·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 316¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀåÀº 2024³â 69¾ï ´Þ·¯¿¡¼­ ¿¹Ãø ±â°£ µ¿¾È CAGR 7.9%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 108¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°èÀÇ °£Áúȯ Ä¡·á ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä, ½ÃÀå ¿µÇâ¿äÀÎ ¹× ½ÃÀå ±âȸ ºÐ¼®, ½ÃÀå ±ÔÁ¦ ȯ°æ, ÆÄÀÌÇÁ¶óÀÎ ºÐ¼®, ½ÃÀå ±Ô¸ð ÃßÁ¤ ¹× ¿¹Ãø, °¢Á¾ ºÎ¹®º°¡¤Áö¿ªº° »ó¼¼ ºÐ¼®, °æÀï ±¸µµ, ÁÖ¿ä ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå °³¿ä

Á¦3Àå ½ÃÀå ¿ªÇÐ

Á¦4Àå ±ÔÁ¦ »óȲ

Á¦5Àå Ãֽе¿Çâ°ú ÆÄÀÌÇÁ¶óÀÎ ºÐ¼®

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®

Á¦7Àå °æÀï Á¤º¸

Á¦8Àå °£Áúȯ Ä¡·á »ê¾÷ÀÇ Áö¼Ó°¡´É¼º : ESG °üÁ¡

Á¦9Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global market for liver disease treatments is estimated to increase from $46.0 billion in 2024 to reach $69.1 billion by 2030, at a compound annual growth rate (CAGR) of 7.1% from 2025 through 2030.

The North American market for liver disease treatments is estimated to increase from $20.8 billion in 2024 to reach $31.6 billion by 2030, at a CAGR of 7.3% from 2025 through 2030.

The Asia-Pacific market for liver disease treatments is estimated to increase from $6.9 billion in 2024 to reach $10.8 billion by 2030, at a CAGR of 7.9% from 2025 through 2030.

Report Scope:

This report on the global market for liver disease treatments provides qualitative and quantitative data on the current market dynamics. It discusses different liver diseases and their treatment modalities.

Analyses of the most frequently used products, clinical trials, new product approvals, and emerging technologies are also included. The demographics of the major regions-North America, Europe, Asia-Pacific, South America, and the Middle East and Africa-as well as their prospects for growth are summarized. The profiles of leading companies in the market and their strategies are also discussed.

The market for liver disease treatments is broken into hepatitis, non-alcoholic fatty liver disease (NAFLD), hepatocellular carcinoma, autoimmune liver diseases, alcohol-induced liver disease (ALD), chronic liver disease, and others. The growth potential and forecast data are discussed for each disease for the aforementioned regions and many countries.

The report includes global revenue in $ millions for the base year of 2024, estimates for 2025, and data for the forecast period of 2026 through 2030.

Report Includes :

Table of Contents

Chapter 1 Executive Summary

Chapter 2 Market Overview

Chapter 3 Market Dynamics

Chapter 4 Regulatory Landscape

Chapter 5 Emerging Trends and Pipeline Analysis

Chapter 6 Market Segmentation Analysis

Chapter 7 Competitive Intelligence

Chapter 8 Sustainability in the Liver Disease Treatment Industry: ESG Perspective

Chapter 9 Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â